BiotechTube
GeneCopoeia

GeneCopoeia

Rockville, United States· Est.
genecopoeia.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15M

Overview

GeneCopoeia is a privately held, revenue-generating provider of essential research tools for the biotechnology and pharmaceutical sectors. Operating as a platform and services business, it supplies high-quality, sequence-verified reagents such as ORF clones, lentiviruses, and stable cell lines to accelerate basic and translational research. The company has strategically expanded its portfolio into high-growth areas like immuno-oncology, exosome research, and COVID-19 tools, positioning itself as a one-stop shop for academic and industrial researchers. Its core value proposition is built on guaranteed sequence accuracy and a broad, integrated product ecosystem.

Genetics & GenomicsDiagnostics

Technology Platform

Integrated platform for molecular biology research, centered on sequence-verified ORF cDNA clones, with extensions into viral delivery systems (lentivirus, AAV), stable cell line engineering, qPCR, and luciferase reporter assays. All clones are fully Sanger sequenced and guaranteed to match NCBI references.

Funding History

1
Total raised:$15M
Series A$15M

Opportunities

Growing demand for validated, assay-ready research tools in complex fields like immuno-oncology and cell therapy presents a significant opportunity.
The company's expansion into bundled product solutions and custom services can increase customer stickiness and average deal size.
Leveraging its sequence verification guarantee as a key differentiator can help capture market share from competitors where quality is a concern.

Risk Factors

Faces intense competition from large, diversified life science conglomerates with greater sales and marketing resources.
Rapid technological change in genomics and molecular biology could render portions of its product portfolio obsolete.
Reliance on academic and biotech research funding makes it susceptible to economic and grant funding cycles.

Competitive Landscape

Operates in the highly competitive life science research tools market, competing against giants like Thermo Fisher Scientific, Merck KGaA (MilliporeSigma), and Agilent, as well as specialized players like Vector Builder, OriGene, and Horizon Discovery. Differentiation is primarily based on product quality (sequence verification), breadth of integrated offerings (clone-to-cell line), and niche focus on specific research areas like immuno-oncology.

More companies in United States →